Back

Stereotactic arrhythmia radioablation in europe: treatment planning benchmark results of the STOPSTORM consortium

3 April 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Moderated ePosters - News on ablation Ablation of Ventricular Arrhythmias EHRA Premium Access EHRA 2022

About the speaker

Photo
Associate Professor Etienne Pruvot

University Hospital Centre Vaudois (CHUV), Lausanne (Switzerland)

7 More presentations in this session

Presentation thumbnail
EGM characteristics of intramural outflow tract ventricular arrhythmias
Doctor A. Soysal (Istanbul, TR)
Abstract Slides
Presentation thumbnail
Recurrences after stereotactic arrhythmia radioablation for refractory ventricular tachycardia
Doctor C. Herrera Siklody (Bern, CH)
Abstract Slides
Presentation thumbnail
Stereotactic body radiotherapy for refractory ventricular tachycardia: the overall czech experience
Associate Professor P. Peichl (Prague, CZ)
Abstract Slides
Presentation thumbnail
Sinus rhythm endocardial mapping for channels identification in ischemic ventricular tachycardia using a modified electrophysiological triad
Professor P. Adragao (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Assessment of optimal thresholds for ventricular scar substrate characterization using the high density grid multipolar mapping catheter
Doctor N. SRINIVASAN (Essex, GB)
Abstract Slides

Access the full session

Session thumbnail
Moderated ePosters - News on ablation

The Event

Event poster

EHRA 2022

3 April - 5 April 2022
You may be interested in
thumbnail
Congress Presentation
Ablation is alternative to ICD therapy in post-myocardial infarction patients with haemodynamically well-tolerated sustained monomorphic VT and LVEF>40%: con
thumbnail
Congress Presentation
Case 1 - first choice treatment: antiarrhythmic drugs or catheter ablation?
thumbnail
Congress Presentation
Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources